Atazanavir 150 mg, 200 mg, 300 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 150 mg, 200 mg, 300 mg
Reference Brands: Reyataz®(EU & US)
Category: Anti Viral
Atazanavir Capsules (150–300 mg), sold under brands like Reyataz® and Atavir®, are protease inhibitors for HIV-1 treatment. Widely used in combination therapy, they’re available for bulk procurement on PharmaB2B platforms from WHO-GMP suppliers—ideal for tenders, NGOs, and HIV programs.
Product Description:
Atazanavir Capsules, marketed globally under brands like Reyataz®, Atavir®, and Atazor®, are essential protease inhibitors used in combination antiretroviral therapy (cART) for HIV-1 treatment. Available in 150 mg, 200 mg, and 300 mg strengths, Atazanavir is often co-administered with Ritonavir to boost its effectiveness. With WHO and USFDA endorsements, PharmaB2B platforms enable global sourcing from GMP-certified manufacturers for bulk procurement, tenders, and public health supply chains. This once-daily dosing option is well-tolerated and vital in global HIV management programs. Partner with trusted suppliers to ensure quality and cost-effective access to key antiretroviral medicines.
Atazanavir — third party manufacturing & bulk supply
Atazanavir 150 mg, 200 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Atazanavir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Atazanavir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Atazanavir is an antiretroviral medication used to treat HIV infection. It works by inhibiting the HIV protease enzyme, preventing the virus from maturing and multiplying, thereby helping to control viral load and improve immune function.
Atazanavir is made from a synthetic protease inhibitor compound that targets HIV protease to block viral replication.
A common trade name for Atazanavir is Reyataz.
Reyataz (Atazanavir) is manufactured by Bristol-Myers Squibb, with multiple generic versions produced by other pharmaceutical companies globally.
The generic name is atazanavir.
The brand name is Reyataz, along with other regional generic brands.
Atazanavir is manufactured in multiple regions, including India, the USA, and Europe, by licensed pharmaceutical manufacturers.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View DetailsLenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers